ConductScience.org, home

Paper2995303

Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.

Perfect JR and 1 other. J Antimicrob Chemother, 1985. Cited by 95 papers, by iCite.

Cite this record

ConductScience Library. Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits. Papers, record 2995303. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2995303

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.
PubMed
Journal
J Antimicrob Chemother
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
95
iCite
Relative citation ratio, by iCite
4.96
iCite
Revised in PubMed
2019-05-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Perfect JRJ R
2Durack DTD T

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antifungal AgentsMajor topic
KetoconazoleMajor topic
Meningitis, HaemophilusMajor topic
TriazolesMajor topic
Animals
Fluconazole
Itraconazole
Rabbits

Source PubMed

Download CSV of topics

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.

PMIDTitleJournalYearIn PapersSource
41599210The Activity of FDA-Approved Prodrug Isavuconazonium Sulfate and Its Major Metabolite Isavuconazole Against Naegleria fowleri.Pharmaceutics2026https://conductscience.org/library/papers/41599210PubMed
39204295Approaches for Targeting Naegleria fowleri Using Nanoparticles and Artificial Peptides.Pathogens2024https://conductscience.org/library/papers/39204295PubMed
38085955Miconazole-like Scaffold is a Promising Lead for Naegleria fowleri-Specific CYP51 Inhibitors.J Med Chem2023https://conductscience.org/library/papers/38085955PubMed
31572393The Rise of Coccidioides: Forces Against the Dust Devil Unleashed.Front Immunol2019https://conductscience.org/library/papers/31572393PubMed
29284029CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM).PLoS Negl Trop Dis2017https://conductscience.org/library/papers/29284029PubMed
20430817Overexpression of TUF1 restores respiratory growth and fluconazole sensitivity to a Cryptococcus neoformans vad1Delta mutant.Microbiology (Reading)2010https://conductscience.org/library/papers/20430817PubMed
18171300The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates.J Infect Dis2008https://conductscience.org/library/papers/18171300PubMed
17178793Comparison of itraconazole and fluconazole treatments in a murine model of coccidioidal meningitis.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17178793PubMed
15227171Systemic antifungal agents.Tex Heart Inst J1990https://conductscience.org/library/papers/15227171PubMed
11706924Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.Paediatr Drugs2001https://conductscience.org/library/papers/11706924PubMed
10817701Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10817701PubMed
10074549Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management.J Clin Microbiol1999https://conductscience.org/library/papers/10074549PubMed
9250423Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.Clin Pharmacokinet1997https://conductscience.org/library/papers/9250423PubMed
8899853Fluconazole distribution to the brain: a crossover study in freely-moving rats using in vivo microdialysis.Pharm Res1996https://conductscience.org/library/papers/8899853PubMed
8557388Influence of serum protein binding on the in vitro activity of anti-fungal agents.Infection1995https://conductscience.org/library/papers/8557388PubMed
8448970Clinical pharmacokinetics of fluconazole.Clin Pharmacokinet1993https://conductscience.org/library/papers/8448970PubMed
8261715Pharmacokinetic optimisation of oral antifungal therapy.Clin Pharmacokinet1993https://conductscience.org/library/papers/8261715PubMed
7811028Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7811028PubMed
7511361Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7511361PubMed
3280211Clinical pharmacokinetics of ketoconazole.Clin Pharmacokinet1988https://conductscience.org/library/papers/3280211PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2995303

GET https://conductscience.org/api/papers/v1/2995303/cited_by?page=2